Pneumatic Nebulizers Market

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report

Global Pneumatic Nebulizers Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2024-2030

Report ID : BMRC 2661
Number of pages : 3000
Published Date : Nov 2023
Category : Medical Device
Delivery Timeline : 48 hrs

Escalating incidences of COPD/asthma patients is one of the prominent factors influencing the market growth. Moreover, intensifying medical and technological advancement across the globe is also fostering market expansion.

The Global Pneumatic Nebulizers Market is valued at USD 846.3 Million in 2022 and is expected to reach USD 1313.4 Million by 2028 with a CAGR of 7.42% over the forecast period.

Scope of Global Pneumatic Nebulizers Market Report

Pneumatic Nebulizers are the earliest form of automizer generation; in fact, they have been commonly used for many years as jet nebulizers. The actual purpose is to create an area to flow driving gas with low pressure above the medication reservoir or generate a vaporizer. Also, these are known as jet nebulizers. These are effective in delivering formulations that cannot be delivered with pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). For instance, antibiotics, mucolytics, liposomal formulations, and recombinant products, such as Pulmozyme Inhalation Solution, are some of the medications that can be delivered via pneumatic nebulizers. The first pneumatic nebulizer consumed from an electrically driven gas compressor was invented in the 1930s and named Pneumostat.

The overall impact of the COVID-19 outbreak has been positive on the pneumatic nebulizer market. On January 30, 2020, the Director-General of the World Health Organization (WHO) announced the outbreak of disease due to a novel coronavirus, a public health disaster of international concern. There has been a heightened use of albuterol nebulizers in hospitals for COVID-19 and supported COVID-19 patients to help with respiratory issues. The main reason for this is that respiratory viruses are the most common trigger for asthma exacerbations.

The global pneumatic nebulizer market is segmented based on product, nozzle, application, age group, end user, and region. Based on product, the pneumatic nebulizer market is segmented into breath-enhanced nebulizers, breath-actuated nebulizers, and others. Based on nozzles, the pneumatic nebulizer market is segmented into internal mixing nozzles and external mixing nozzles. Based on application, the pneumatic nebulizer market is segmented into asthma, COPD, cystic fibrosis, and bronchiectasis. Based on age group, the pneumatic nebulizer market is segmented into pediatric, neonatal, adult, and geriatric. Based on end users, the pneumatic nebulizer market is segmented into hospitals, clinics, homecare settings, and others.

The regions covered in this pneumatic nebulizer market is North America, Europe, Asia-Pacific, Latin, and the Middle East. Based on a country level, the Pneumatic Nebulizers market is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players for Global Pneumatic Nebulizers Market Report

Some of the key players for pneumatic nebulizers are Philips Healthcare, Omron Corporation, PARI GmbH DeVilbiss Healthcare, Drive DeVilbiss Healthcare, Rossmax International Ltd., Becton, Dickinson and Company, Agilent Technologies, Aerogen, Medline Industries, Inc., GF Health Products, Inc. (Graham-Field), Briggs Healthcare, Salter Labs, Fisons, Smiths Medical, Clement Clarke International, Heyer Medical AG, Besmed Health Business Corp., Bremed Ltd., BLS Systems Limited, 3A Health Care, Mabis Healthcare, Cirrus Healthcare Products LLC, DeVilbiss Healthcare LLC, Salter Labs LLC, Teleflex, VORTRAN Medical Technology, SDI Diagnostics, Briggs Healthcare LLC, Medel S.p.A. and Others.


Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19

May 6th, 2021- Vectura Group plc and Inspira Pharmaceuticals Limited were both leading inhalation companies focused on developing therapies for respiratory and infectious diseases which also include nebulizers. They announced an accord to develop an inhaled expression of Inspira’s lead drug candidate for the treatment of COVID-19.

Global Pneumatic Nebulizers Market Drivers

Rising dominance of COPD/asthma patients is boosting the growth of the pneumatic nebulizers market. Bronchial asthma/COPD is a condition in which a person’s airways getting inflamed and difficult to breath. Important risk factors causing asthma and COPD, environmental exposure to tobacco smoke, air pollution, and occupational dust, chemicals, odors, etc.

For instance, as per WHOs research, nearly 262 million people disturbed by asthma and triggered 455000 deaths. Thus, for them pneumatic nebulizer is an appliance which can deliver asthma medicine deeply in the lungs. Inbreathe medication can control asthma symptoms and consent to people with asthma/COPD leading a normal, active life. This is why, rising number of asthma/COPD patients increase the demand for pneumatic nebulizers.

In addition, the escalating progress in both the medical and technological domains is fostering an increased demand for pneumatic nebulizers. These devices are primarily employed for the administration of bronchodilators, a well-established method known to elicit a physiological response, and their cost-effectiveness further bolsters their utility. Key market players are actively engaged in enhancing nebulizer performance, a notable endeavour given the introduction of new, relatively expensive drugs suitable for nebulization, necessitating precise dosing. As of February 22, 2023, the World Health Organization (WHO) highlights the unprecedented pace of healthcare innovation, particularly in the digital realm, underscoring the dynamic landscape of the healthcare industry.

Global Pneumatic Nebulizers Market Restraint & Opportunity

The Global Pneumatic Nebulizers Market faces a challenge in terms of increasing competition from ultrasonic and mesh nebulizers, which are more compact and offer quieter operation. Pneumatic nebulizers are relatively bulkier and can produce more noise, making them less attractive for some patients. Market players must address this competition to maintain their market share.

An opportunity lies in the growing prevalence of respiratory diseases such as asthma, COPD, and cystic fibrosis, particularly in emerging economies. The need for efficient aerosol drug delivery systems is on the rise. Pneumatic nebulizers have the advantage of delivering a wide range of medications effectively, presenting an opportunity for market growth, especially in regions with an expanding patient pool.

Global Pneumatic Nebulizers Market Regional Analysis

Geographically, North America is reckoned to generate significant returns over the estimated timeframe owing to the surge in the elderly population base, the growing prevalence of pulmonary diseases, rising health awareness, and technological developments. As the prevalence of chronic respiratory disease increased, demand for home healthcare devices, i.e., pneumatic nebulizers, increased in the U.S. For instance, according to the American Association, there may be around 25 million people who suffer from asthma in the U.S., of which about 20 million are adults in 2021. So, these factors are responsible for pneumatic nebulizer market growth in this region.

Also, Europe is reported as the second-dominating region for pneumatic nebulizers, which is a constantly growing market with increasing urbanization and a rising prevalence of asthma and COPD. Likewise, technological advancement is boosting the European market for pneumatic nebulizers. Some key players are investing significantly in smart nebulizers, which can be used by both children and adults. The European Union organizes well-described activities to influence an outbreak of asthma within a nation or region. For instance, in the past few years, the European government organized the 7th framework program, EARIP-European Asthma Research and Innovation Partnership, with the goal of reducing asthma mortality by approximately 25% in 10 years and by 50% within 20 years. In this way, the market is growing for pneumatic nebulizers.

Key Benefits of Global Pneumatic Nebulizers Market Report

  • Global pneumatic nebulizers market report covers in-depth historical and forecasts analysis.
  • Global pneumatic nebulizers market research report provides detailed information about introduction, summary, global revenue (Revenue USD), drivers, restraints, opportunities, competitive analysis, regional and country level.
  • Global pneumatic nebulizers market report helps to identify opportunities in the place.
  • Global pneumatic nebulizers market report covers extensive analysis of emerging trends and competitive landscape.

Global Pneumatic Nebulizers Market Segmentation:

By Product:

  • Breath-enhanced nebulizers
  • Breath-actuated nebulizers
  • Others

By Nozzle:

  • Internal mixing nozzle
  • External mixing nozzle

By Application:

  • Asthma
  • COPD
  • Cystic fibrosis
  • Bronchiectasis

By age-group:

  • Pediatric
  • Neonatal
  • Adult
  • Geriatric

By End User:

  • Hospitals
  • Clinics
  • Homecare settings

By Regional & Country Analysis:

  • North America
  • US.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • The Asia Pacific
  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Rest of Latin America
  • The Middle East and Africa
  • GCCcountries
  • Africa
  • Rest of the Middle East and Africa
Vishal Sawant
Business Development
+91 8830 254 358

By Product

  • Breath-enhanced nebulizers
  • Breath-actuated nebulizers
  • Others

By Nozzle

  • Internal mixing nozzle
  • External mixing nozzle

By Age-group

  • Pediatric
  • Neonatal
  • Adult
  • Geriatric

By Application

  • Asthma
  • COPD
  • Cystic fibrosis
  • Bronchiectasis

By End User

  • Hospitals
  • Clinics
  • Homecare settings
Regions and Country

North America

  • U.S.
  • Canada


  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe


  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Key Players
  • 3A Health Care
  • Aerogen
  • Agilent Technologies
  • Becton
  • Besmed Health Business Corp.
  • BLS Systems Limited
  • Bremed Ltd.
  • Briggs Healthcare
  • Cirrus Healthcare Products LLC
  • Clement Clarke International
  • DeVilbiss Healthcare LLC
  • Dickinson and Company
  • Drive DeVilbiss Healthcare
  • Fisons
  • GF Health Products, Inc. (Graham-Field)
  • Heyer Medical AG
  • Mabis Healthcare
  • Medel S.p.A.
  • Medline Industries, Inc.
  • Omron Corporation
  • PARI GmbH
  • Philips Healthcare
  • Rossmax International Ltd.
  • Salter Labs LLC
  • SDI Diagnostics
  • Smiths Medical
  • Teleflex
  • VORTRAN Medical Technology
  • Others


We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us



BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX




1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®